Open access
1,754
Views
0
CrossRef citations to date
0
Altmetric
Drug Evaluation
Etranacogene dezaparvovec-drlb gene therapy for patients with hemophilia B (congenital factor IX deficiency)
Tro Sekayana Division of Hematology/Oncology, Department of Medicine, University of California, San Diego, San Diego, CA, USACorrespondence[email protected]
https://orcid.org/0009-0009-7050-0020View further author information
, https://orcid.org/0009-0009-7050-0020View further author information
Dana H. Simmonsb Capitol Scientific, Washington DC, USAhttps://orcid.org/0000-0003-4852-4703View further author information
& Annette von Drygalskia Division of Hematology/Oncology, Department of Medicine, University of California, San Diego, San Diego, CA, USAhttps://orcid.org/0000-0002-9426-6322View further author information
Pages 1173-1184
|
Received 23 Aug 2023, Accepted 07 Nov 2023, Published online: 23 Nov 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.